Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-012502
Filing Date
2022-12-13
Accepted
2022-12-13 17:25:26
Documents
1
Period of Report
2022-12-09

Document Format Files

Seq Description Document Type Size
1 form4-12132022_051201.html 4  
1 form4-12132022_051201.xml 4 7171
  Complete submission text file 0001415889-22-012502.txt   8610
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

EIN.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address
Laccona Nicholas (Reporting) CIK: 0001886497 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 221460519